Kerecis

[3][4] The decellularized skin of the Atlantic cod is used as a graft, which increases the elasticity, tensile strength, and compressibility of the wound.

[11] Kerecis Omega-3 fish skin was cleared for use by the FDA in 2013 for the treatment of chronic and acute wounds.

[15] In 2016, Omega3 Wound, a fish skin treatment developed by Kereceis, was approved by the US Food and Drug Administration.

[11] In 2021, FDA approved Kerecis Omega3 SurgiBind, fish-skin for surgical use that is useful in plastic and reconstructive surgery.

[19] Kereceis also works on medical research with the US Armed Forces and provides the grafts to branches of the military.